$Molecular (MOLN.US)$ Novartis NVS, +1.16% NOVN, 0.58% also ...
$Molecular(MOLN.US$ Novartis NVS, +1.16% NOVN, 0.58% also said it will exercise its option and pay 150 million Swiss francs ($163.3 million) to in-license ensovibep from Molecular Partners MOLN, -3.39% MOLN, 29.21% and accelerate manufacturing scale-up.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
风光3265 : @Mcsnacks H TupackIs it appropriate to buy today
Mcsnacks H TupackOP 风光3265: I’m not liking the way the market is acting